CMV IgG
Brief Description
The LIAISON XL® CMV IgG assay uses chemiluminescence immunoassay (CLIA) technology on the LIAISON XL® Analyzer family* for the qualitative determination of IgG antibodies to human cytomegalovirus (hCMV) in human serum. It is intended to be used as an aid in the determination of serological status to CMV. This assay is not FDA-cleared for use in testing (i.e., screening) blood or plasma donors. The performance characteristics of this assay have not been established for cord blood or specimens from neonates, infants, or pre-transplant patients.
Laboratory Unit
Immunology
Methodology
Chemiluminescence Immunoassay (CLIA)
Specimen Collection
Serum:
Collect in gold top SST tube, centrifuge
Collect in tiger top SST tube, centrifuge
Storage/Transport
Serum separated from the clot can be maintained at refrigerated temperature (2-8°C) during transit for no more than two days after collection.
Serum separated from the clot should be dispensed in aliquots, stored frozen (-20°C or colder) and shipped with dry ice. Pack specimens in compliance with government regulations covering the transportation of etiologic agents.
Acceptable Specimen Type(s)
Serum
Test Request
- GPHL Apollo Web Portal
-
Web
Portal Instructions
- For manual orders, download the
GPHL
Submission Form
Possible Results
- Positive
- Negative
- Unsatisfactory
- Equivocal
Reference Range
Negative
Unacceptable Conditions
- Plasma Specimens
- Missing testing requisition
- Missing minimum of 2 patient identifiers
- Improper labeling
- Improper storage/transport of specimen
- No specimen received (empty collection tube).
- Wrong specimen type
- Low volume
- Specimen damaged, broken, or leaking upon arrival
- Grossly hemolyzed, icteric or lipemic
- Specimen containing microbial contamination
- Received more than 2 Days after collection
Interfering Substances
Hemolysis, icterus, lipemia, and bacterial contamination
Result Reported
5-7 business days
Fees
LOINC/Order Codes
22244-8 (Order code: 1515)